{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T04:20:03Z","timestamp":1784607603936,"version":"3.55.0"},"reference-count":115,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Steroids"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/j.steroids.2022.108989","type":"journal-article","created":{"date-parts":[[2022,2,18]],"date-time":"2022-02-18T11:04:17Z","timestamp":1645182257000},"page":"108989","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome"],"prefix":"10.1016","volume":"180","author":[{"given":"Neil R.","family":"Chappell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E.","family":"Gibbons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chellakkan S.","family":"Blesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0005","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/nrendo.2010.217","article-title":"Polycystic ovary syndrome: etiology, pathogenesis and diagnosis","volume":"7","author":"Goodarzi","year":"2011","journal-title":"Nat. Rev. Endocrinol."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0010","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.fertnstert.2016.05.009","article-title":"Introduction: Determinants of polycystic ovary syndrome","volume":"106","author":"Azziz","year":"2016","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2022.108989_b0015","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.bpobgyn.2016.03.005","article-title":"Hypothalamic-pituitary, ovarian and adrenal contributions to polycystic ovary syndrome","volume":"37","author":"Baskind","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0020","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1097\/MED.0b013e32832afd4d","article-title":"Androgens and polycystic ovary syndrome","volume":"16","author":"Nisenblat","year":"2009","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"key":"10.1016\/j.steroids.2022.108989_b0025","doi-asserted-by":"crossref","first-page":"745","DOI":"10.2147\/IJWH.S70314","article-title":"Complications and challenges associated with polycystic ovary syndrome: current perspectives","volume":"7","author":"Palomba","year":"2015","journal-title":"Int J Womens Health"},{"key":"10.1016\/j.steroids.2022.108989_b0030","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.ejogrb.2014.02.041","article-title":"A comparison of the miscarriage rate between women with and without polycystic ovarian syndrome undergoing IVF treatment","volume":"176","author":"Liu","year":"2014","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0035","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.rbmo.2017.07.010","article-title":"Early miscarriage rate in lean polycystic ovary syndrome women after euploid embryo transfer - a matched-pair study","volume":"35","author":"Luo","year":"2017","journal-title":"Reprod Biomed Online"},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0040","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1016\/j.fertnstert.2013.12.030","article-title":"Maternal characteristics and pregnancy outcomes after assisted reproductive technology by infertility diagnosis: ovulatory dysfunction versus tubal obstruction","volume":"101","author":"Grigorescu","year":"2014","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0045","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.tem.2010.12.002","article-title":"Metabolic syndrome and oocyte quality","volume":"22","author":"Cardozo","year":"2011","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0050","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tem.2016.11.008","article-title":"Oocyte Competence in Women with Polycystic Ovary Syndrome","volume":"28","author":"Palomba","year":"2017","journal-title":"Trends Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0055","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1055\/s-2008-1042958","article-title":"Oocyte quality in adult polycystic ovary syndrome","volume":"26","author":"Patel","year":"2008","journal-title":"Semin Reprod Med"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0060","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.pathophys.2008.04.004","article-title":"Evidence that obesity alters the quality of oocytes and embryos","volume":"15","author":"Robker","year":"2008","journal-title":"Pathophysiology"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0065","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11154-007-9046-0","article-title":"Polycystic ovary syndrome and its developmental origins","volume":"8","author":"Dumesic","year":"2007","journal-title":"Rev. Endocr. Metab. Disord."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0070","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1210\/jcem.87.3.8287","article-title":"Impaired developmental competence of oocytes in adult prenatally androgenized female rhesus monkeys undergoing gonadotropin stimulation for in vitro fertilization","volume":"87","author":"Dumesic","year":"2002","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0075","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1016\/j.fertnstert.2017.09.030","article-title":"Polycystic ovary syndrome, an enigmatic syndrome begging for a name change","volume":"108","author":"Rosenwaks","year":"2017","journal-title":"Fertil. Steril."},{"key":"10.1016\/j.steroids.2022.108989_b0080","doi-asserted-by":"crossref","unstructured":"E.A.-S.P.C.W.G. Rotterdam, Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome, Fertil Steril 81(1) (2004) 19-25.","DOI":"10.1016\/j.fertnstert.2003.10.004"},{"issue":"11","key":"10.1016\/j.steroids.2022.108989_b0085","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.3390\/ijerph15112589","article-title":"Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race\/Ethnicity","volume":"15","author":"Wolf","year":"2018","journal-title":"Int. J. Environ. Res. Public Health"},{"issue":"11","key":"10.1016\/j.steroids.2022.108989_b0090","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jc.2010-0202","article-title":"The polycystic ovary post-rotterdam: a common, age-dependent finding in ovulatory women without metabolic significance","volume":"95","author":"Johnstone","year":"2010","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0095","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.fertnstert.2014.09.040","article-title":"Is polycystic ovarian morphology related to a poor oocyte quality after controlled ovarian hyperstimulation for intracytoplasmic sperm injection?","volume":"103","author":"Sigala","year":"2015","journal-title":"Results from a prospective, comparative study, Fertil Steril"},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0100","first-page":"251","article-title":"Recommendations from the international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"89","author":"Teede","year":"2018","journal-title":"Fertil. Steril."},{"issue":"5 Suppl","key":"10.1016\/j.steroids.2022.108989_b0105","first-page":"S219","article-title":"Current evaluation of amenorrhea","volume":"90","author":"Practice Committee of American Society for Reproductive","year":"2008","journal-title":"Fertil. Steril."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0110","doi-asserted-by":"crossref","first-page":"R193","DOI":"10.1530\/REP-14-0517","article-title":"Role of androgens in normal and pathological ovarian function","volume":"149","author":"Walters","year":"2015","journal-title":"Reproduction"},{"issue":"12","key":"10.1016\/j.steroids.2022.108989_b0115","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: a systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0120","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.fertnstert.2017.01.017","article-title":"Obesity and female infertility: potential mediators of obesity's impact","volume":"107","author":"Broughton","year":"2017","journal-title":"Fertil. Steril."},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0125","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.fertnstert.2015.08.018","article-title":"Obesity and reproduction: a committee opinion","volume":"104","author":"Practice Committee of the American Society for Reproductive","year":"2015","journal-title":"Fertil. Steril."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0130","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/AOG.0b013e31821fd360","article-title":"Effect of obesity on oocyte and embryo quality in women undergoing in vitro fertilization","volume":"118","author":"Shah","year":"2011","journal-title":"Obstet. Gynecol."},{"issue":"9","key":"10.1016\/j.steroids.2022.108989_b0135","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1001\/jama.2014.10432","article-title":"Assessment and lifestyle management of patients with obesity: clinical recommendations from systematic reviews","volume":"312","author":"Kushner","year":"2014","journal-title":"JAMA"},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0140","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.7092","article-title":"Associations of Weight Gain From Early to Middle Adulthood With Major Health Outcomes Later in Life","volume":"318","author":"Zheng","year":"2017","journal-title":"JAMA"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajog.2014.03.035","article-title":"Effect of body mass index on in vitro fertilization outcomes in women with polycystic ovary syndrome","volume":"211","author":"Bailey","year":"2014","journal-title":"Am. J. Obstet. Gynecol."},{"issue":"6","key":"10.1016\/j.steroids.2022.108989_b0150","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.1016\/j.fertnstert.2007.10.077","article-title":"Effects of polycystic ovarian syndrome on in vitro fertilization-embryo transfer outcomes are influenced by body mass index","volume":"90","author":"McCormick","year":"2008","journal-title":"Fertil. Steril."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0155","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ejogrb.2004.07.038","article-title":"Reactive hypoglycemia in lean young women with PCOS and correlations with insulin sensitivity and with beta cell function","volume":"119","author":"Altuntas","year":"2005","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0160","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1007\/s00404-013-2833-9","article-title":"Anti-Mullerian hormone and insulin resistance in classic phenotype lean PCOS","volume":"288","author":"Caglar","year":"2013","journal-title":"Arch. Gynecol. Obstet."},{"issue":"9","key":"10.1016\/j.steroids.2022.108989_b0165","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-0032-1309006","article-title":"Lean muscle mass in classic or ovulatory PCOS: association with central obesity and insulin resistance","volume":"120","author":"Mario","year":"2012","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"issue":"mar09 2","key":"10.1016\/j.steroids.2022.108989_b0170","doi-asserted-by":"crossref","first-page":"b954","DOI":"10.1136\/bmj.b954","article-title":"Even lean women with PCOS are insulin resistant","volume":"338","author":"Shumak","year":"2009","journal-title":"BMJ"},{"issue":"9","key":"10.1016\/j.steroids.2022.108989_b0175","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s10815-015-0540-0","article-title":"Antimullerian hormone levels are inversely associated with body mass index (BMI) in women with polycystic ovary syndrome","volume":"32","author":"Kriseman","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"issue":"9","key":"10.1016\/j.steroids.2022.108989_b0180","doi-asserted-by":"crossref","first-page":"3288","DOI":"10.1210\/jc.2016-1340","article-title":"Baseline AMH Level Associated With Ovulation Following Ovulation Induction in Women With Polycystic Ovary Syndrome","volume":"101","author":"Mumford","year":"2016","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0185","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.xfre.2020.05.006","article-title":"Embryos from polycystic ovary syndrome patients with hyperandrogenemia reach morula stage faster than controls","volume":"1","author":"Chappell","year":"2020","journal-title":"F&S Reports"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0190","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.rbmo.2019.03.203","article-title":"A meta-analysis of pregnancy-related outcomes and complications in women with polycystic ovary syndrome undergoing IVF","volume":"39","author":"Sha","year":"2019","journal-title":"Reprod Biomed Online"},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0195","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s10815-016-0830-1","article-title":"Effect of body mass index on the outcomes of controlled ovarian hyperstimulation in Chinese women with polycystic ovary syndrome: a multicenter, prospective, observational study","volume":"34","author":"Sheng","year":"2017","journal-title":"J. Assist. Reprod. Genet."},{"issue":"11","key":"10.1016\/j.steroids.2022.108989_b0200","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1007\/s10815-018-1290-6","article-title":"The effect of female body mass index on in vitro fertilization cycle outcomes: a multi-center analysis","volume":"35","author":"Kudesia","year":"2018","journal-title":"J. Assist. Reprod. Genet."},{"key":"10.1016\/j.steroids.2022.108989_b0205","doi-asserted-by":"crossref","first-page":"6434080","DOI":"10.1155\/2020\/6434080","article-title":"Association between Body Mass Index and Reproductive Outcome in Women with Polycystic Ovary Syndrome Receiving IVF\/ICSI-ET","volume":"2020","author":"Zhou","year":"2020","journal-title":"Biomed Res. Int."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0210","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1093\/humupd\/dmi036","article-title":"A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome","volume":"12","author":"Heijnen","year":"2006","journal-title":"Hum Reprod Update"},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0215","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1097\/OGX.0b013e31815e85fc","article-title":"Polycystic ovary syndrome and oocyte developmental competence","volume":"63","author":"Dumesic","year":"2008","journal-title":"Obstet. Gynecol. Surv."},{"issue":"6","key":"10.1016\/j.steroids.2022.108989_b0220","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.tibtech.2010.03.002","article-title":"Single cell analysis: the new frontier in 'omics'","volume":"28","author":"Wang","year":"2010","journal-title":"Trends Biotechnol."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0225","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1186\/s13059-017-1218-y","article-title":"Challenges and emerging directions in single-cell analysis","volume":"18","author":"Yuan","year":"2017","journal-title":"Genome Biol."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0230","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/hast.1215","article-title":"Rethinking Human Embryo Research Policies","volume":"51","author":"Matthews","year":"2021","journal-title":"Hastings Cent. Rep."},{"key":"10.1016\/j.steroids.2022.108989_b0235","doi-asserted-by":"crossref","unstructured":"F. Ethics in Embryo Research Task, a.a.o. Ethics Committee of the American Society for Reproductive Medicine. Electronic address, M. Ethics Committee of the American Society for Reproductive, Ethics in embryo research: a position statement by the ASRM Ethics in Embryo Research Task Force and the ASRM Ethics Committee, Fertil Steril 113(2) (2020) 270-294.","DOI":"10.1016\/j.fertnstert.2019.10.012"},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0240","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1210\/me.2003-0326","article-title":"Androgens promote maturation and signaling in mouse oocytes independent of transcription: a release of inhibition model for mammalian oocyte meiosis","volume":"18","author":"Gill","year":"2004","journal-title":"Mol. Endocrinol."},{"key":"10.1016\/j.steroids.2022.108989_b0245","series-title":"Clinical gynecologic endocrinology and infertility","author":"Fritz","year":"2011"},{"issue":"8","key":"10.1016\/j.steroids.2022.108989_b0250","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1073\/pnas.1318978111","article-title":"Androgens regulate ovarian follicular development by increasing follicle stimulating hormone receptor and microRNA-125b expression","volume":"111","author":"Sen","year":"2014","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0255","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1210\/endo.133.5.8404672","article-title":"Estrogens inhibit and androgens enhance ovarian granulosa cell apoptosis","volume":"133","author":"Billig","year":"1993","journal-title":"Endocrinology"},{"key":"10.1016\/j.steroids.2022.108989_b0260","doi-asserted-by":"crossref","first-page":"452","DOI":"10.3389\/fendo.2018.00452","article-title":"Androgen Action in the Ovary","volume":"9","author":"Franks","year":"2018","journal-title":"Front. Endocrinol. (Lausanne)"},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0265","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1095\/biolreprod.107.064089","article-title":"Androgen actions and the ovary","volume":"78","author":"Walters","year":"2008","journal-title":"Biol. Reprod."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0270","doi-asserted-by":"crossref","first-page":"190","DOI":"10.14310\/horm.2002.1580","article-title":"Androgens as double-edged swords: Induction and suppression of follicular development","volume":"14","author":"Pan","year":"2015","journal-title":"Hormones (Athens)"},{"issue":"Suppl 1","key":"10.1016\/j.steroids.2022.108989_b0275","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1016\/j.fertnstert.2006.03.015","article-title":"Ovarian enzyme activities in women with polycystic ovary syndrome","volume":"86","author":"Magoffin","year":"2006","journal-title":"Fertil. Steril."},{"issue":"6","key":"10.1016\/j.steroids.2022.108989_b0280","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1093\/humupd\/dmw027","article-title":"Interactions between androgens, FSH, anti-Mullerian hormone and estradiol during folliculogenesis in the human normal and polycystic ovary","volume":"22","author":"Dewailly","year":"2016","journal-title":"Hum Reprod Update"},{"issue":"12","key":"10.1016\/j.steroids.2022.108989_b0285","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.1093\/humrep\/15.12.2471","article-title":"Comparison of follicle steroidogenesis from normal and polycystic ovaries in women undergoing IVF: relationship between steroid concentrations, follicle size, oocyte quality and fecundability","volume":"15","author":"Teissier","year":"2000","journal-title":"Hum. Reprod."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0290","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1097\/MED.0000000000000246","article-title":"Androgen action in female reproductive physiology","volume":"23","author":"Walters","year":"2016","journal-title":"Curr. Opin. Endocrinol. Diabetes Obes."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0295","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1210\/jcem-50-4-640","article-title":"Intraovarian sex steroid hormone interactions and the regulation of follicular maturation: aromatization of androgens by human granulosa cells in vitro","volume":"50","author":"Hillier","year":"1980","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"8","key":"10.1016\/j.steroids.2022.108989_b0300","doi-asserted-by":"crossref","first-page":"3146","DOI":"10.1210\/en.2014-1196","article-title":"Characterization of reproductive, metabolic, and endocrine features of polycystic ovary syndrome in female hyperandrogenic mouse models","volume":"155","author":"Caldwell","year":"2014","journal-title":"Endocrinology"},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0305","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.repbio.2013.09.007","article-title":"Mouse models to study polycystic ovary syndrome: a possible link between metabolism and ovarian function?","volume":"14","author":"van Houten","year":"2014","journal-title":"Reprod. Biol."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0310","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/S1043-2760(98)00019-8","article-title":"Insights into the development of polycystic ovary syndrome (PCOS) from studies of prenatally androgenized female rhesus monkeys","volume":"9","author":"Abbott","year":"1998","journal-title":"Trends Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0315","doi-asserted-by":"crossref","first-page":"e0122370","DOI":"10.1371\/journal.pone.0122370","article-title":"Impaired oocyte quality induced by dehydroepiandrosterone is partially rescued by metformin treatment","volume":"10","author":"Huang","year":"2015","journal-title":"PLoS One"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0320","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.fertnstert.2011.11.040","article-title":"Androstenedione induces abnormalities in morphology and function of developing oocytes, which impairs oocyte meiotic competence","volume":"97","author":"Tarumi","year":"2012","journal-title":"Fertil. Steril."},{"issue":"12","key":"10.1016\/j.steroids.2022.108989_b0325","doi-asserted-by":"crossref","first-page":"4835","DOI":"10.1210\/en.2012-2140","article-title":"DHEA-mediated inhibition of the pentose phosphate pathway alters oocyte lipid metabolism in mice","volume":"154","author":"Jimenez","year":"2013","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0330","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1210\/en.2012-1954","article-title":"Estradiol negative and positive feedback in a prenatal androgen-induced mouse model of polycystic ovarian syndrome","volume":"154","author":"Moore","year":"2013","journal-title":"Endocrinology"},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0335","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1073\/pnas.1415038112","article-title":"Enhancement of a robust arcuate GABAergic input to gonadotropin-releasing hormone neurons in a model of polycystic ovarian syndrome","volume":"112","author":"Moore","year":"2015","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0340","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.yfrne.2014.04.002","article-title":"Reproductive neuroendocrine dysfunction in polycystic ovary syndrome: insight from animal models","volume":"35","author":"Roland","year":"2014","journal-title":"Front. Neuroendocrinol."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0345","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1677\/JOE-10-0217","article-title":"Prenatal androgen exposure programs metabolic dysfunction in female mice","volume":"207","author":"Roland","year":"2010","journal-title":"J. Endocrinol."},{"issue":"18","key":"10.1016\/j.steroids.2022.108989_b0350","doi-asserted-by":"crossref","first-page":"7129","DOI":"10.1073\/pnas.0308058101","article-title":"Prenatal androgens alter GABAergic drive to gonadotropin-releasing hormone neurons: implications for a common fertility disorder","volume":"101","author":"Sullivan","year":"2004","journal-title":"Proc. Natl. Acad. Sci. U.S.A"},{"key":"10.1016\/j.steroids.2022.108989_b0355","doi-asserted-by":"crossref","first-page":"105830","DOI":"10.1016\/j.jsbmb.2021.105830","article-title":"Fetal Programming of Polycystic Ovary Syndrome: Effects of Androgen Exposure on Prenatal Ovarian Development","volume":"207","author":"Barsky","year":"2021","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0360","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1093\/toxsci\/kfl064","article-title":"Dehydroepiandrosterone inhibits complex I of the mitochondrial respiratory chain and is neurotoxic in vitro and in vivo at high concentrations","volume":"93","author":"Safiulina","year":"2006","journal-title":"Toxicol. Sci."},{"issue":"12","key":"10.1016\/j.steroids.2022.108989_b0365","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1038\/s41591-019-0666-1","article-title":"Prenatal androgen exposure and transgenerational susceptibility to polycystic ovary syndrome","volume":"25","author":"Risal","year":"2019","journal-title":"Nat. Med."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0370","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/j.arr.2013.09.001","article-title":"Actions of 17beta-estradiol and testosterone in the mitochondria and their implications in aging","volume":"12","author":"Vasconsuelo","year":"2013","journal-title":"Ageing Res Rev"},{"key":"10.1016\/j.steroids.2022.108989_b0375","article-title":"Hyperandrogenemia alters Mitochondrial Structure and Function in the Oocytes of Obese PCOS Mouse, F&S","author":"Chappell","year":"2020","journal-title":"Science"},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0380","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1530\/EC-19-0553","article-title":"Prenatal androgen induced lean PCOS impairs mitochondria and mRNA profiles in oocytes","volume":"9","author":"Chappell","year":"2020","journal-title":"Endocrine connections"},{"key":"10.1016\/j.steroids.2022.108989_b0385","doi-asserted-by":"crossref","first-page":"396","DOI":"10.3389\/fgene.2020.00396","article-title":"Single-Cell Transcriptomic Analysis Reveals Mitochondrial Dynamics in Oocytes of Patients With Polycystic Ovary Syndrome","volume":"11","author":"Qi","year":"2020","journal-title":"Front. Genet."},{"issue":"Suppl 4","key":"10.1016\/j.steroids.2022.108989_b0390","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/j.1439-0531.2012.02069.x","article-title":"Factors affecting oocyte and embryo transcriptomes","volume":"47","author":"Sirard","year":"2012","journal-title":"Reprod. Domest. Anim."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0395","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1210\/jc.2006-2123","article-title":"Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis","volume":"92","author":"Wood","year":"2007","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2022.108989_b0400","doi-asserted-by":"crossref","first-page":"5403904","DOI":"10.1155\/2020\/5403904","article-title":"Involvement of GJA1 and Gap Junctional Intercellular Communication between Cumulus Cells and Oocytes from Women with PCOS","volume":"2020","author":"Liu","year":"2020","journal-title":"Biomed Res. Int."},{"key":"10.1016\/j.steroids.2022.108989_b0405","first-page":"39638","article-title":"Single-cell analysis of differences in transcriptomic profiles of oocytes and cumulus cells at GV","volume":"6","author":"Liu","year":"2016","journal-title":"MI, MII stages from PCOS patients, Sci Rep"},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0410","doi-asserted-by":"crossref","first-page":"R79","DOI":"10.1530\/REP-18-0583","article-title":"Obesity induces ovarian inflammation and reduces oocyte quality","volume":"158","author":"Snider","year":"2019","journal-title":"Reproduction"},{"issue":"6","key":"10.1016\/j.steroids.2022.108989_b0415","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0099423","article-title":"Effects of 5alpha-dihydrotestosterone and 17beta-estradiol on the mouse ovarian follicle development and oocyte maturation","volume":"9","author":"Tarumi","year":"2014","journal-title":"PLoS ONE"},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0420","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1016\/j.mito.2010.09.012","article-title":"Mitochondrial function in the human oocyte and embryo and their role in developmental competence","volume":"11","author":"Van Blerkom","year":"2011","journal-title":"Mitochondrion"},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0425","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1093\/humrep\/des079","article-title":"Time-lapse monitoring as a tool for clinical embryo assessment","volume":"27","author":"Kirkegaard","year":"2012","journal-title":"Hum. Reprod."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0430","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.rbmo.2014.04.011","article-title":"Limitations of a time-lapse blastocyst prediction model: a large multicentre outcome analysis","volume":"29","author":"Kirkegaard","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0435","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.fertnstert.2017.07.1156","article-title":"Effectiveness and safety of time-lapse imaging for embryo culture and selection: it is still too early for any conclusions?","volume":"108","author":"Racowsky","year":"2017","journal-title":"Fertil. Steril."},{"issue":"3","key":"10.1016\/j.steroids.2022.108989_b0440","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/humrep\/des438","article-title":"Similar morphokinetic patterns in embryos derived from obese and normoweight infertile women: a time-lapse study","volume":"28","author":"Bellver","year":"2013","journal-title":"Hum. Reprod."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0445","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1016\/j.rbmo.2013.11.017","article-title":"Impact of PCOS on early embryo cleavage kinetics","volume":"28","author":"Wissing","year":"2014","journal-title":"Reprod Biomed Online"},{"issue":"7","key":"10.1016\/j.steroids.2022.108989_b0450","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s10815-015-0488-0","article-title":"Unaltered timing of embryo development in women with polycystic ovarian syndrome (PCOS): a time-lapse study","volume":"32","author":"Sundvall","year":"2015","journal-title":"J. Assist. Reprod. Genet."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0455","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.rbmo.2018.10.010","article-title":"Association between early embryo morphokinetics plus cumulus cell gene expression and assisted reproduction outcomes in polycystic ovary syndrome women","volume":"38","author":"Tabibnejad","year":"2019","journal-title":"Reprod. Biomed. Online"},{"issue":"8","key":"10.1016\/j.steroids.2022.108989_b0460","doi-asserted-by":"crossref","first-page":"483","DOI":"10.29252\/ijrm.16.8.483","article-title":"Serum Anti-Mullerian hormone and embryo morphokinetics detecting by time-lapse imaging: A comparison between the polycystic ovarian syndrome and tubal factor infertility","volume":"16","author":"Tabibnejad","year":"2018","journal-title":"Int J Reprod Biomed (Yazd)"},{"key":"10.1016\/j.steroids.2022.108989_b0465","doi-asserted-by":"crossref","unstructured":"M. Tam Le, T. Van Nguyen, T. Thanh Nguyen, T. Thanh Thi Nguyen, T. An Thi Nguyen, Q. Huy Vu Nguyen, N. Thanh Cao, Does polycystic ovary syndrome affect morphokinetics or abnormalities in early embryonic development?, Eur. J. Obstet. Gynecol. Reprod. Biol. X 3 (2019) 100045.","DOI":"10.1016\/j.eurox.2019.100045"},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0470","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa010","article-title":"Animal Models to Understand the Etiology and Pathophysiology of Polycystic Ovary Syndrome","volume":"41","author":"Stener-Victorin","year":"2020","journal-title":"Endocr. Rev."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0475","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ydbio.2014.08.028","article-title":"Cell fate regulation during preimplantation development: a view of adhesion-linked molecular interactions","volume":"395","author":"Sozen","year":"2014","journal-title":"Dev. Biol."},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0480","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.tice.2015.06.003","article-title":"Effects of androgen on immunohistochemical localization of androgen receptor and Connexin 43 in mouse ovary","volume":"47","author":"Yang","year":"2015","journal-title":"Tissue Cell"},{"issue":"7","key":"10.1016\/j.steroids.2022.108989_b0485","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1177\/1933719113519169","article-title":"Histomorphometric Analysis and Markers of Endometrial Receptivity Embryonic Implantation in Women With Polycystic Ovary Syndrome During the Treatment With Progesterone","volume":"21","author":"Lopes","year":"2014","journal-title":"Reprod. Sci."},{"key":"10.1016\/j.steroids.2022.108989_b0490","doi-asserted-by":"crossref","first-page":"7502","DOI":"10.1038\/ncomms8502","article-title":"Genome-wide association of polycystic ovary syndrome implicates alterations in gonadotropin secretion in European ancestry populations","volume":"6","author":"Hayes","year":"2015","journal-title":"Nat. Commun."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0495","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1055\/s-0036-1585403","article-title":"Genome-Wide Association Studies for Polycystic Ovary Syndrome","volume":"34","author":"Liu","year":"2016","journal-title":"Semin. Reprod. Med."},{"key":"10.1016\/j.steroids.2022.108989_b0500","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.bpobgyn.2016.04.002","article-title":"Genetic Studies on Polycystic Ovary Syndrome","volume":"37","author":"Zhao","year":"2016","journal-title":"Best Pract. Res. Clin. Obstet. Gynaecol."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0505","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.celrep.2016.05.065","article-title":"Maternal Metabolic Syndrome Programs Mitochondrial Dysfunction via Germline Changes across Three Generations","volume":"16","author":"Saben","year":"2016","journal-title":"Cell Rep."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0510","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1093\/molehr\/gau042","article-title":"Developmental programming of obesity and insulin resistance: does mitochondrial dysfunction in oocytes play a role?","volume":"21","author":"Turner","year":"2015","journal-title":"Mol. Hum. Reprod."},{"issue":"4","key":"10.1016\/j.steroids.2022.108989_b0515","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1093\/humupd\/dmi013","article-title":"Androgen excess fetal programming of female reproduction: a developmental aetiology for polycystic ovary syndrome?","volume":"11","author":"Abbott","year":"2005","journal-title":"Hum. Reprod. Update"},{"issue":"12","key":"10.1016\/j.steroids.2022.108989_b0520","article-title":"Naturally Occurring and Experimentally Induced Rhesus Macaque Models for Polycystic Ovary Syndrome: Translational Gateways to Clinical Application","volume":"7","author":"Abbott","year":"2019","journal-title":"Med. Sci. (Basel)"},{"issue":"11","key":"10.1016\/j.steroids.2022.108989_b0525","doi-asserted-by":"crossref","first-page":"E1292","DOI":"10.1152\/ajpendo.00310.2013","article-title":"Effects of hyperandrogenemia and increased adiposity on reproductive and metabolic parameters in young adult female monkeys","volume":"306","author":"McGee","year":"2014","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"5","key":"10.1016\/j.steroids.2022.108989_b0530","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1210\/jc.2005-2757","article-title":"Review: fetal programming of polycystic ovary syndrome by androgen excess: evidence from experimental, clinical, and genetic association studies","volume":"91","author":"Xita","year":"2006","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"10.1016\/j.steroids.2022.108989_b0535","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.fertnstert.2016.09.042","article-title":"Endocrine and cardiometabolic cord blood characteristics of offspring born to mothers with and without polycystic ovary syndrome","volume":"107","author":"Daan","year":"2017","journal-title":"Fertil. Steril."},{"issue":"03","key":"10.1016\/j.steroids.2022.108989_b0540","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1055\/s-0034-1371087","article-title":"Intrauterine environment and polycystic ovary syndrome","volume":"32","author":"Dumesic","year":"2014","journal-title":"Semin. Reprod. Med."},{"issue":"2","key":"10.1016\/j.steroids.2022.108989_b0545","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1080\/17446651.2019.1576522","article-title":"Hyperandrogenic origins of polycystic ovary syndrome - implications for pathophysiology and therapy","volume":"14","author":"Abbott","year":"2019","journal-title":"Expert Rev. Endocrinol. Metab."},{"key":"10.1016\/j.steroids.2022.108989_b0550","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/j.jsbmb.2015.09.003","article-title":"Increased androgen levels in rats impair glucose-stimulated insulin secretion through disruption of pancreatic beta cell mitochondrial function","volume":"154","author":"Wang","year":"2015","journal-title":"J. Steroid Biochem. Mol. Biol."},{"issue":"8","key":"10.1016\/j.steroids.2022.108989_b0555","doi-asserted-by":"crossref","first-page":"3284","DOI":"10.1021\/acs.jproteome.5b00307","article-title":"NMR Metabolomics Show Evidence for Mitochondrial Oxidative Stress in a Mouse Model of Polycystic Ovary Syndrome","volume":"14","author":"Selen","year":"2015","journal-title":"J. Proteome Res."},{"issue":"7","key":"10.1016\/j.steroids.2022.108989_b0560","first-page":"931","article-title":"Insulin Resistance","volume":"1","author":"Cree-Green","year":"2017","journal-title":"Hyperinsulinemia, and Mitochondria Dysfunction in Nonobese Girls With Polycystic Ovarian Syndrome, J Endocr Soc"},{"key":"10.1016\/j.steroids.2022.108989_b0565","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.freeradbiomed.2015.05.013","article-title":"Metabolism alteration in follicular niche: The nexus among intermediary metabolism, mitochondrial function, and classic polycystic ovary syndrome","volume":"86","author":"Zhao","year":"2015","journal-title":"Free Radic. Biol. Med."},{"issue":"6","key":"10.1016\/j.steroids.2022.108989_b0570","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.3390\/nu13061848","article-title":"Polycystic Ovary Syndrome in Insulin-Resistant Adolescents with Obesity: The Role of Nutrition Therapy and Food Supplements as a Strategy to Protect Fertility","volume":"13","author":"Calcaterra","year":"2021","journal-title":"Nutrients"},{"issue":"12","key":"10.1016\/j.steroids.2022.108989_b0575","first-page":"865","article-title":"The role of melatonin in polycystic ovary syndrome: A review","volume":"17","author":"Mojaverrostami","year":"2019","journal-title":"Int. J. Reprod. Biomed."}],"container-title":["Steroids"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000277?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0039128X22000277?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,22]],"date-time":"2025-09-22T10:08:16Z","timestamp":1758535696000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0039128X22000277"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,4]]},"references-count":115,"alternative-id":["S0039128X22000277"],"URL":"https:\/\/doi.org\/10.1016\/j.steroids.2022.108989","relation":{},"ISSN":["0039-128X"],"issn-type":[{"value":"0039-128X","type":"print"}],"subject":[],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pathology of hyperandrogenemia in the oocyte of polycystic ovary syndrome","name":"articletitle","label":"Article Title"},{"value":"Steroids","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.steroids.2022.108989","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"108989"}}